BRIACELL THERAP Reported Earnings

BRIACELL THERAP (BCTX) reported a loss of $1.24 per share on revenue of $0.00 million for the . .

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the BriaVax vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.